Elanco Vira Shield 4 + VL5 HB Vaccine 250 mL/50 Dose
For use in healthy breeding cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR) and bovine virus diarrhea (BVD Type 1 and BVD Type 2) viruses and Campylobacter fetus, Leptospira canicola, grippotyphosa, hardjo-bovis, icterohaemorrhagiae, and pomona.
**Ships Monday thru Thursday Only**
See our Pharmaceutical Quality Program for more info.
This product is non-returnable.
Elanco Vira Shield 4 + VL5 HB Vaccine 250 mL/50 Dose
Vira Shield leads the way in providing a complete line of flexible, safe, and powerful inactivated vaccines that protect against up to 13 respiratory, reproductive and leptospirosis diseases.
Easy to implement in any management program or whole-herd protocol, Vira Shield 6 combinations can be used in pregnant cows, heifers and calves nursing pregnant cows. Vira Shield has been shown to protect against infectious bovine rhinotracheitis (IBR) abortion eight months post vaccination.1
Unlike vaccines that carry label restrictions and products that require cows to be vaccinated prior to breeding, Vira Shield is easy to implement into any management program or whole-herd protocol.1 State-of-the-art adjuvant Xtend® SP prolongs stimulation of the immune system.2 Vira Shield delivers broad-spectrum, field-proven protection against the most devastating diseases.
- Safe for use on all cattle, even pregnant cows and calves nursing pregnant cows
- 12-month duration of immunity label claim for Lepto hardjo-bovis, the most common cause of leptospirosis in the US3
- The only inactivated vaccine to feature 3-way BVD coverage including cytopathic (CP) Type 1, noncytopathic (NCP) Type 1 and Type 2
- Demonstrated to protect against IBR abortion eight months post vaccination
- Provides both humoral and cell-mediated immunity4
- Powerful, long-lasting control with state-of-the-art adjuvant, Xtend® SP
For use in healthy breeding cattle, including pregnant cows and heifers, as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR) and bovine virus diarrhea (BVD Type 1 and BVD Type 2) viruses and Campylobacter fetus, Leptospira canicola, grippotyphosa, hardjo-bovis, icterohaemorrhagiae, and pomona. For use in calves vaccinated at four weeks of age, or older, as an aid in the prevention of hardjo-bovis kidney colonization, and as an aid in preventing urinary shedding and reproductive tract infection for 12 months. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates. Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo-bovis) have been shown to clear renal infections within 8 weeks of exposure.
DIRECTIONS: Shake well before using. Administer 5 mL subcutaneously 2-4 weeks prior to breeding. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate in 4-5 weeks. Revaccinate annually or as recommended by your veterinarian.
| Item Number | EAH010 |
|---|---|
| MPN | AV611050DAM |
| UPC | 634406003756 |
| Weight | 2.000000 |
| Brand | Elanco |
| Item Returns | This item can be returned |